Physician profile
David Kim
NPI 1700992534
$2,012.26
in general payments reported to CMS, 2019-2025
7 companies · $23.86 in 2025
The $23.86 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $573 · 2020: $285 · 2021: $365 · 2022: $393 · 2023: $156 · 2024: $217 · 2025: $23.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $243 · Food and Beverage: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $243.31 |
| Food and Beverage | $153.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironwood Pharmaceuticals, INC | $513.18 | 2019-2024 | |
| Ferring Pharmaceuticals INC. | $503.08 | 2019-2022 | |
| Braintree Laboratories, INC. | $449.83 | 2021-2024 | Sutab, Suflave |
| Abbvie INC. | $317.35 | 2019-2024 | |
| Gilead Sciences, INC. | $125.00 | 2019 | |
| Allergan, INC. | $65.56 | 2019-2020 | |
| Novo Nordisk INC | $38.26 | 2019-2025 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.